Cellectar plans Phase III start in late Q4 2026 as it outlines potential WM approval in the second half of 2027
Cellectar Biosciences INC NEW · PHARMACEUTICAL PREPARATIONS · Now $2.97
-4.4% in 3d after detection
Post-detection moves
1h
—
1d
-3.4%
3d
-4.4%
7d
-3.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS